Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lowered its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.7% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,007,324 shares of the company’s stock after selling 148,747 shares during the quarter. Dimensional Fund Advisors LP owned approximately 6.05% of Prestige Consumer Healthcare worth $207,057,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in PBH. Principal Securities Inc. acquired a new position in Prestige Consumer Healthcare during the 4th quarter valued at approximately $29,000. Vanguard Personalized Indexing Management LLC acquired a new position in Prestige Consumer Healthcare during the 4th quarter worth $222,000. Quadrant Capital Group LLC boosted its position in Prestige Consumer Healthcare by 29.3% during the 4th quarter. Quadrant Capital Group LLC now owns 1,660 shares of the company’s stock worth $102,000 after acquiring an additional 376 shares during the period. Norges Bank acquired a new position in Prestige Consumer Healthcare during the 4th quarter worth $27,739,000. Finally, UBS Group AG boosted its position in Prestige Consumer Healthcare by 377.6% during the 4th quarter. UBS Group AG now owns 131,382 shares of the company’s stock worth $8,043,000 after acquiring an additional 103,872 shares during the period. Institutional investors and hedge funds own 99.95% of the company’s stock.

Prestige Consumer Healthcare Trading Up 0.6 %

Shares of Prestige Consumer Healthcare stock opened at $73.94 on Friday. The business has a fifty day simple moving average of $71.16 and a 200-day simple moving average of $69.67. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.34 and a fifty-two week high of $75.80. The firm has a market cap of $3.66 billion, a price-to-earnings ratio of 17.73, a price-to-earnings-growth ratio of 2.06 and a beta of 0.48. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65.

Prestige Consumer Healthcare (NYSE:PBH) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.90 earnings per share for the quarter, beating analysts’ consensus estimates of $0.86 by $0.04. The company had revenue of $267.10 million during the quarter, compared to the consensus estimate of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. Prestige Consumer Healthcare’s revenue was down 4.4% on a year-over-year basis. During the same period in the prior year, the company earned $1.06 EPS. On average, equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.42 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, DA Davidson boosted their price target on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a “buy” rating in a research report on Wednesday, August 28th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, Prestige Consumer Healthcare has an average rating of “Moderate Buy” and an average price target of $98.75.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.